| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | 12.970 | 116.574 | 139.774 |
| Total Income - EUR | - | - | - | - | - | - | - | 12.970 | 116.574 | 139.774 |
| Total Expenses - EUR | - | - | - | - | - | - | - | 611 | 10.514 | 14.269 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | 12.359 | 106.060 | 125.505 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | 12.230 | 104.894 | 121.312 |
| Employees | - | - | - | - | - | - | - | 1 | 1 | 1 |
Check the financial reports for the company - Kris-Endoclinic S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | - | - | 12.954 | 106.303 | 123.909 |
| Inventories | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | - | 0 | 87.827 | 85.109 |
| Cash | - | - | - | - | - | - | - | 12.954 | 18.476 | 38.800 |
| Shareholders Funds | - | - | - | - | - | - | - | 12.270 | 104.935 | 121.353 |
| Social Capital | - | - | - | - | - | - | - | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | - | 684 | 1.368 | 2.557 |
| Income in Advance | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Kris-Endoclinic S.r.l.